Mexican President Claudia Sheinbaum says her government is not ruling out filing a civil lawsuit against Google if it ...

Hey savvy investors! Today’s video is one I never thought I’d make, because I’m seriously reconsidering my position in Mapletree Pan Asia Commercial Trust or MPACT. Viewers of ‘The Dividend Uncle’ ...

Parts of Britain are likely to be blasted by the freezing weather, as the latest weather maps have turned icy blue, indicating the possibility of low temperatures. According to the weather maps ...

JAKARTA - Indonesia’s antitrust agency on Jan 21 ordered Google to pay fines of around 202 billion rupiah (S$16.7 million) for unfair business practices related to its payment system services ...

and fostering strategic partnerships makes him uniquely qualified to lead Blue Ocean's future in the Asia-Pacific region," said Brian Hyndman, Chief Executive Officer, and President of Blue Ocean ...

Trump promised to impose tariffs of 60 percent on all Chinese exports and to boost the U.S. defense budget, focusing it more on Asia and possibly less on Europe, including Ukraine. But he also ...

After years of refinement, Apple Maps is pretty good now. I switch between Google Maps and Apple Maps regularly, mostly as an experiment, and at this point I think Apple's product is just as ...

(Bloomberg) — Emirati firm Fertiglobe Plc intends to invest more than $1 billion to produce cleaner ammonia if it gets commitments to buy from Asia. Japan and South Korea ... a final investment ...

Abu Dhabi-listed Fertiglobe plans to invest more than $1 billion (3.67 billion UAE dirhams) to produce blue ammonia depending on securing purchase commitments from Asia, according to a media report.

UK weather maps are turning icy blue with Britons bracing for a teeth-shattering -9C Arctic blast to hit the country in a matter of days. WXCharts has forecast wintery weather to sweep over the UK ...

As the J.P. Morgan Healthcare Conference started in San Francisco on Monday, AbbVie linked up with Simcere with a $1 billion deal for the Chinese biopharma's phase 1 T-cell engager. Later during ...